Weindler J, Mohamed G, Lieblang S, Ruprecht K W
Augenklinik und Poliklinik, Universität des Saarlandes, Homburg/Saar.
Anaesthesist. 1996 Sep;45(9):826-33. doi: 10.1007/s001010050317.
The number of surgical procedures performed as day surgery has significantly increased in recent years. Therefore, a safe and short postoperative recovery period has become increasingly important. The aim of the present study was to investigate perioperative cognitive and physiological function after oral premedication with low-dose midazolam (3.75 mg), especially during the postoperative period.
Forty-seven men (age > 69 years, weight 50-90 kg) scheduled for elective cataract surgery under retrobulbar anaesthesia (RBA) were included in the study. The patients were randomly assigned to either group 1 (n = 28), receiving 3.75 mg midazolam p.o. (Dormicum), or group 2 (n = 19), receiving a placebo orally 30 min before RBA. We measured the following parameters: sedation (modified Glasgow coma scale); anxiety (visual analogue scale); numerical and verbal memory (digit span and reproduction of previously presented words); concentration (Revisions test of Stender/Marschner). To identify depression of ventilation, pulse oximetry and nasal end-tidal PCO2 were monitored intraoperatively.
After premedication with 3.75 mg midazolam, patients were significantly more sedated (P < 0.01) and systolic blood pressures were significantly reduced (P < 0.05); 30 min after midazolam premedication only concentration was significantly (P < 0.05) decreased. The results of the other cognitive functions did not differ. No differences in cognitive and physiological functions between and groups could be found 2 h after the operation (293 +/- min after premedication). Intraoperatively, there were no significant differences in end-tidal PCO2 and oxygenation between the groups. In both groups anxiety and blood pressure were significantly higher pre- than postoperatively.
Oral administration of low-dose midazolam (0.049 +/- mg/kg) seems to be appropriate for premedication before ambulatory surgical procedures in elderly patients. In the interest of patient safety, standardised oral premedication with 3.75 mg midazolam may not be sufficient for some of the patients.
近年来,日间手术的手术量显著增加。因此,安全且术后恢复期短变得越来越重要。本研究的目的是调查口服低剂量咪达唑仑(3.75毫克)进行术前用药后围手术期的认知和生理功能,尤其是术后期间。
纳入47名计划在球后麻醉(RBA)下进行择期白内障手术的男性(年龄>69岁,体重50 - 90千克)。患者被随机分为1组(n = 28),口服3.75毫克咪达唑仑(多美康),或2组(n = 19),在RBA前30分钟口服安慰剂。我们测量了以下参数:镇静程度(改良格拉斯哥昏迷量表);焦虑程度(视觉模拟量表);数字和语言记忆(数字广度和对先前呈现单词的再现);注意力(施滕德/马斯chner修订测试)。为了确定通气抑制情况,术中监测脉搏血氧饱和度和鼻腔呼气末二氧化碳分压。
口服3.75毫克咪达唑仑进行术前用药后,患者的镇静程度显著更高(P < 0.01),收缩压显著降低(P < 0.05);咪达唑仑术前用药30分钟后仅注意力显著降低(P < 0.05)。其他认知功能的结果没有差异。术后2小时(术前用药后293±分钟),两组之间的认知和生理功能没有差异。术中,两组之间呼气末二氧化碳分压和氧合没有显著差异。两组中,术前焦虑和血压均显著高于术后。
口服低剂量咪达唑仑(0.049±毫克/千克)似乎适用于老年患者门诊手术前的术前用药。为了患者安全,对于一些患者,3.75毫克咪达唑仑的标准化口服术前用药可能不够。